Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chatterji, M.
Right arrow Articles by Nagaraja, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chatterji, M.
Right arrow Articles by Nagaraja, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 479-485
© 2001 The British Society for Antimicrobial Chemotherapy

Effect of different classes of inhibitors on DNA gyrase from Mycobacterium smegmatis

Monalisa Chatterji, Shyam Unniraman, Sethuraman Mahadevan and Valakunja Nagaraja,*

Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India 560012

Quinolones, coumarins, cyclothialidines, CcdB and microcin B17 inhibit DNA gyrase. Information regarding these various inhibitors comes from studies performed with the enzyme from Escherichia coli, and subsequent analyses have also primarily been confined to this system. We have carried out a detailed analysis of the effect of various groups of inhibitors on Mycobacterium smegmatis gyrase and demonstrate differential susceptibility of the E. coli and M. smegmatis gyrases. Interestingly, M. smegmatis gyrase was refractory to the plasmid-borne proteinaceous inhibitors CcdB and microcin B17. Ciprofloxacin, a fluoroquinolone, showed a 10-fold reduction in efficacy against M. smegmatis compared with E. coli gyrase. We have also shown that etoposide, an antineoplastic drug, inhibits DNA gyrase activity by trapping the gyrase–DNA complex. DNA gyrases from both E. coli and M. smegmatis were susceptible to etoposide at comparable levels.

* Corresponding author. Tel: +91-80-360-0668; Fax: +91-80-360-2697; E-mail: vraj{at}mcbl.iisc.ernet.in


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Microbiol. Mol. Biol. Rev.Home page
E. C. Hett and E. J. Rubin
Bacterial Growth and Cell Division: a Mycobacterial Perspective
Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 126 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Sengupta, M. Shah, and V. Nagaraja
Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-binding
Nucleic Acids Res., November 14, 2006; 34(19): 5567 - 5576.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
U. H. Manjunatha, A. Maxwell, and V. Nagaraja
A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism
Nucleic Acids Res., June 1, 2005; 33(10): 3085 - 3094.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
T. Gruger, J. L. Nitiss, A. Maxwell, E. L. Zechiedrich, P. Heisig, S. Seeber, Y. Pommier, and D. Strumberg
A Mutation in Escherichia coli DNA Gyrase Conferring Quinolone Resistance Results in Sensitivity to Drugs Targeting Eukaryotic Topoisomerase II
Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4495 - 4504.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
U. H. Manjunatha, M. Dalal, M. Chatterji, D. R. Radha, S. S. Visweswariah, and V. Nagaraja
Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase
Nucleic Acids Res., May 15, 2002; 30(10): 2144 - 2153.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.